Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Prepaid Assets (2016 - 2025)

RedHill Biopharma has reported Prepaid Assets over the past 10 years, most recently at $2.5 million for Q4 2025.

  • Quarterly Prepaid Assets rose 124.46% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 124.46% year-over-year, with the annual reading at $2.5 million for FY2025, 124.46% up from the prior year.
  • Prepaid Assets was $2.5 million for Q4 2025 at RedHill Biopharma, up from $1.0 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $5.2 million in Q1 2023 and troughed at $1.0 million in Q2 2025.
  • The 5-year median for Prepaid Assets is $3.3 million (2022), against an average of $3.3 million.
  • Year-over-year, Prepaid Assets soared 155.24% in 2021 and then plummeted 65.28% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $4.7 million in 2021, then dropped by 5.88% to $4.4 million in 2022, then plummeted by 36.15% to $2.8 million in 2023, then tumbled by 60.59% to $1.1 million in 2024, then surged by 124.46% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for RDHL's Prepaid Assets are $2.5 million (Q4 2025), $1.0 million (Q2 2025), and $1.1 million (Q4 2024).